Unchained Labs, a Pleasanton, CA-based startup life sciences tools company, raised $25m in Series A Financing.
The round was led by Novo Ventures, Canaan Partners and TPG Biotech.
Led by Founder and CEO Tim Harkness, Unchained Labs also acquired Optim, a multiplex protein stability platform for biologics, from The Avacta Group. Its derived product, Optim, allows researchers to measure multiple protein stability parameters – including denaturing temperature and aggregation onset temperature – on multiple samples simultaneously.
Over 60 Optim platforms have been sold to biopharma and academic customers worldwide.
The company plans to continue to buy businesses and product lines for developing products and selling them.
FinSMEs
12/02/2015